Evonik Corporation

Evonik serves as an end-to-end development partner and solution provider for medical device companies. As a global leader for innovative biomaterials and related application services, Evonik offers an integrated portfolio. This includes RESOMER®, the world’s leading portfolio of bioresorbable polymers, which is for use with implantable medical devices via various processing technologies, including 3D-printing. Another portfolio highlight is Evonik’s clinically proven ENDEXO® surface modification technology, which is based on low-molecular-weight oligomers to enhance the biocompatibility of medical devices such as cardiovascular, neurovascular, and renal applications.